Based on well-characterized molecular features, BC could be categorized into four subtypes, basal-like, luminal A, luminal B, and Her2+ tumors, which exhibit distinct oncogenic activation pathways, tumor progression pattern and prognostic outcomes [24], [25]. Here, ERBB2 is linked to neoplasm.